ImmunityBio, Inc.
IBRX
$7.25
$0.081.12%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 380.88M | 242.82M | 257.81M | 153.66M | 61.59M |
| Total Receivables | 43.27M | 42.62M | 33.72M | 22.33M | 17.45M |
| Inventory | 547.00K | 910.00K | 6.70M | 6.64M | 8.44M |
| Prepaid Expenses | 18.92M | 16.85M | 19.02M | 15.85M | 13.62M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 9.33M | 11.68M | 12.25M | 9.65M | 8.05M |
| Total Current Assets | 452.95M | 314.88M | 329.50M | 208.13M | 109.16M |
|
|
|||||
| Total Current Assets | 452.95M | 314.88M | 329.50M | 208.13M | 109.16M |
| Net Property, Plant & Equipment | 146.08M | 147.55M | 163.08M | 168.03M | 167.05M |
| Long-term Investments | 910.00K | 910.00K | 910.00K | 910.00K | 910.00K |
| Goodwill | 910.00K | 910.00K | 910.00K | 910.00K | 910.00K |
| Total Other Intangibles | 11.98M | 13.04M | 13.57M | 14.07M | 14.53M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 34.72M | 11.32M | 11.24M | 10.24M | 11.40M |
| Total Assets | 646.64M | 501.90M | 518.99M | 402.08M | 303.76M |
|
|
|||||
| Total Accounts Payable | 11.19M | 6.98M | 5.77M | 7.42M | 13.50M |
| Total Accrued Expenses | 44.87M | 42.01M | 39.33M | 33.89M | 25.59M |
| Short-term Debt | 884.00K | 1.75M | 2.60M | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.68M | 7.59M | 7.37M | 7.44M | 7.46M |
| Total Finance Division Other Current Liabilities | 3.33M | 3.42M | 2.07M | 1.90M | 2.66M |
| Total Other Current Liabilities | 3.33M | 3.42M | 2.07M | 1.90M | 2.66M |
| Total Current Liabilities | 67.95M | 61.75M | 57.13M | 50.64M | 49.21M |
|
|
|||||
| Total Current Liabilities | 67.95M | 61.75M | 57.13M | 50.64M | 49.21M |
| Long-Term Debt | 1.08B | 801.71M | 816.95M | 799.13M | 782.00M |
| Short-term Debt | 884.00K | 1.75M | 2.60M | -- | -- |
| Capital Leases | 33.36M | 33.67M | 34.37M | 36.09M | 33.10M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 331.77M | 104.34M | 133.94M | 86.03M | 29.94M |
| Total Liabilities | 1.52B | 1.00B | 1.04B | 971.90M | 894.24M |
|
|
|||||
| Common Stock & APIC | 3.46B | 3.20B | 3.14B | 3.01B | 2.89B |
| Retained Earnings | -4.36B | -3.73B | -3.66B | -3.60B | -3.50B |
| Treasury Stock & Other | 27.45M | 28.96M | 5.00M | 12.57M | 19.96M |
| Total Common Equity | -870.01M | -500.47M | -524.32M | -570.75M | -591.43M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -870.01M | -500.47M | -524.32M | -570.75M | -591.43M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 880.00K | 895.00K | 909.00K | 930.00K | 949.00K |
| Total Equity | -869.13M | -499.57M | -523.41M | -569.82M | -590.48M |
|
|
|||||